Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125363031 | 12536303 | 1 | I | 20160223 | 20160701 | 20160707 | 20160707 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607000199 | ELI LILLY AND CO | 66.46 | YR | M | Y | 0.00000 | 20160706 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125363031 | 12536303 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | UNK, UNKNOWN | N | 21462 | INJECTION | ||||||||
| 125363031 | 12536303 | 2 | SS | CISPLATYL | CISPLATIN | 1 | Unknown | UNK, UNKNOWN | N | 0 | |||||||||
| 125363031 | 12536303 | 3 | C | PREVISCAN /00261401/ | PENTOXIFYLLINE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125363031 | 12536303 | 4 | C | FLECAINE | FLECAINIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125363031 | 12536303 | 5 | C | TEMERIT | NEBIVOLOL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125363031 | 12536303 | 6 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125363031 | 12536303 | 7 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125363031 | 12536303 | 1 | Pleural mesothelioma |
| 125363031 | 12536303 | 2 | Pleural mesothelioma |
| 125363031 | 12536303 | 3 | Atrial fibrillation |
| 125363031 | 12536303 | 4 | Heart rate abnormal |
| 125363031 | 12536303 | 5 | Hypertension |
| 125363031 | 12536303 | 6 | Hypercholesterolaemia |
| 125363031 | 12536303 | 7 | Hypokalaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125363031 | 12536303 | HO |
| 125363031 | 12536303 | LT |
| 125363031 | 12536303 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125363031 | 12536303 | General physical health deterioration | |
| 125363031 | 12536303 | Haemoglobin decreased | |
| 125363031 | 12536303 | Haemoptysis | |
| 125363031 | 12536303 | Haemothorax | |
| 125363031 | 12536303 | Hypovolaemic shock | |
| 125363031 | 12536303 | International normalised ratio increased | |
| 125363031 | 12536303 | Neutropenia | |
| 125363031 | 12536303 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125363031 | 12536303 | 1 | 20160210 | 20160210 | 0 | |
| 125363031 | 12536303 | 2 | 20160210 | 20160210 | 0 |